Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg/Kgevery 8 Hours for Three Consecutive Days After Surgery.
Recruiting now · Phase 2
Conditions studied: Patients Who Undergo Pancreaticoduodenectomy
In brief
Exploring the effectiveness and safety of early use of Ariceptinfen after pancreaticoduodenectomy in alleviating postoperative pain and promoting recovery of patients. Main objective: To explore the analgesic effect of Anricfen after pancreaticoduodenectomy. Secondary objective: To explore the impact of Anricfen on the accelerated recovery after pancreaticoduodenectomy. Exploratory objective: To investigate the biomarkers of Anricfen's analgesic effect after pancreaticoduodenectomy, as well as its correlation factors with tumor pathology.
Key facts
- Study ID
- NCT07514637
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- People needed
- 35
- Starts
- 2025-11-25
- Expected to finish
- 2026-03-31
- Last updated by the study team
- 2026-04-07
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who underwent pancreatic surgery, including pancreaticoduodenectomy (PD), pancreatic-preserving pancreaticoduodenectomy (PPPD), and laparoscopic pancreaticoduodenectomy (LPD)
- Age ≥ 18 years old and < 80 years old
- ASA Ⅰ-Ⅲ
- Be able to clearly understand and voluntarily participate in the research
You may not qualify if…
- Merging severe primary diseases involving the heart, brain, liver, kidneys and hematopoietic system
- History of long-term use of psychotropic drugs and cognitive dysfunction
- Having a history of acute poisoning from alcohol, sleeping pills, painkillers or other drugs that affect the central nervous system
- Pregnancy or lactation period
- History of allergy to NSAIDs, opioids, or to the test medication
- Drug users, alcoholics, and opiate abusers
- Those who had a history of chronic pain before the operation and a history of long-term use of analgesics and/or sedatives
- Those who had thyroid dysfunction before the operation
Where it is running
- NanJing drum tower hospital — Nanjing, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.